Cryopyrin-associated Periodic Syndromes (CAPS)

DBCOND0048690Congenital, Hereditary, and Neonatal Diseases and Abnormalitiesimmediate and delayed hypersensitivity reactions

Cryopyrin-associated Periodic Syndromes (CAPS) is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Cryopyrin-Associated Periodic Syndromes · Cryopyrin-Associated Periodic Syndrome · Cryopyrin Associated Periodic Syndrome
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0527944ICD-10M04.2SNOMED CT15123008MedDRA10064568UMLSC0268390

What you can answer from here — as of October 22, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
36Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Cryopyrin-associated Periodic Syndromes (CAPS) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In